Buspirone as a Potential Treatment for Recurrent Central Apnea
Status:
Terminated
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether buspirone compared to acetazolamide and to
placebo will reduce the number and/or severity of breathing pauses during sleep that occur in
some patients with Heart Failure.